Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 3 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Preclinical evaluation and pilot clinical study of [68Ga]Ga-THP-APN09, a novel PD-L1 targeted nanobody radiotracer for rapid one-step radiolabeling and PET imaging.
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3838-3850. doi: 10.1007/s00259-023-06373-3. Epub 2023 Aug 9.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 37555904
Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside.
Li L, Lin X, Wang L, Ma X, Zeng Z, Liu F, Jia B, Zhu H, Wu A, Yang Z.
Li L, et al.
Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3735-3749. doi: 10.1007/s00259-023-06313-1. Epub 2023 Jun 29.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 37382662
Clinical Trial.
Item in Clipboard
High in-vivo stability in preclinical and first-in-human experiments with [18F]AlF-RESCA-MIRC213: a 18F-labeled nanobody as PET radiotracer for diagnosis of HER2-positive cancers.
Qin X, Guo X, Liu T, Li L, Zhou N, Ma X, Meng X, Liu J, Zhu H, Jia B, Yang Z.
Qin X, et al.
Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):302-313. doi: 10.1007/s00259-022-05967-7. Epub 2022 Sep 21.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 36129493
Item in Clipboard
Cite
Cite